Capital Fund Management (CFM)
CDLX icon

Capital Fund Management (CFM)’s Cardlytics CDLX Stock Holding History

Capital Fund Management (CFM)’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,440
Closed -$792K – 1442
2022
Q1 		$792K Buy
+1,440
New +$870K 0.01% 1216
2021
Q4 		– Sell
-1,470
Closed -$1.23M – 1608
2021
Q3 		$1.23M Buy
+1,470
New +$1.49M 0.01% 1113

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Fund Management (CFM)'s CDLX Position: Q3 2021 in Review

Capital Fund Management (CFM) sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 1,361 shares — an estimated $1.38M sold.

Capital Fund Management (CFM) first reported a position in CDLX in Q2 2021 and held it in 1 quarter. The position peaked at $1.73M in Q2 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.

  • Capital Fund Management (CFM) reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 1,361 Cardlytics shares in Q3 2021, an estimated $1.38M.
  • Capital Fund Management (CFM) first reported a position in Cardlytics in Q2 2021 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Cardlytics position peaked at $1.73M in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2021, filed 12 Nov 2021.